Plasmodium MSP1-p19 Recombinant Protein from ProteoGenix; catalogue PX-P2080; research use only.
Know who made it. See the evidence. Buy through one marketplace.
MSP1-p19 (Merozoite surface proteins) is a protein located on the surface of Plasmodium falciparum merozoites. The protein is a good target for vaccine development against malaria, a disease caused by protozoans because they are accessible to antibodies in the plasma. It also induce both inhibitory as well as blocking antibodies, the latter blocking the protective effects of the former. The malaria parasite, in its asexual, blood invading stage called the merozoite stage, infects red blood cells. The MSP1 complex of surface proteins likely mediates the first interactions of the parasite with red blood cells.
ProteoGenix catalogue number PX-P2080. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Purity: 80%; Molecular weight: 23.79 kDa; Fragment: Partial; Buffer: PBS, pH 7.5; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
